메뉴 건너뛰기




Volumn 22, Issue 24, 2012, Pages 7512-7517

Inhibition of HIV-1 capsid assembly: Optimization of the antiviral potency by site selective modifications at N1, C2 and C16 of a 5-(5-furan-2-yl-pyrazol- 1-yl)-1H-benzimidazole scaffold

Author keywords

Benzimidazole; Capsid assembly inhibitor; HIV 1; X ray crystal structure

Indexed keywords

5 (5 FURAN 2 YL PYRAZOL 1 YL) 1H BENZIMIDAZOLE; ANTIVIRUS AGENT; BENZIMIDAZOLE; UNCLASSIFIED DRUG;

EID: 84870249453     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2012.10.034     Document Type: Article
Times cited : (31)

References (28)
  • 1
    • 84871251786 scopus 로고    scopus 로고
    • November 2009, Geneva. (accessed May 2012)
    • UNAIDS/WHO "AIDS Epidemic Update 2009", November 2009, Geneva. http://data.unaids.org/pub/Report/2009/JC1700-Epi-Update-2009-en.pdf (accessed May 2012).
    • UNAIDS/WHO "aIDS Epidemic Update 2009"
  • 2
    • 73549103358 scopus 로고    scopus 로고
    • For a recent review about the impact of antiretroviral therapy on HIV pandemic, see
    • For a recent review about the impact of antiretroviral therapy on HIV pandemic, see: S. Broder Antiviral Res. 85 2010 1
    • (2010) Antiviral Res. , vol.85 , pp. 1
    • Broder, S.1
  • 23
    • 84870250887 scopus 로고    scopus 로고
    • WO 2007048042
    • Prevelige, P. WO 2007048042, 2007.
    • (2007) Prevelige P.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.